the efficacy and safety of intravenous infusion of human tissue-type plasminogen activator ( rt-pa ) , developed in japan ( td-2061 ) , were investigated in 205 patients ( 154 men and 51 women ) with evolving myocardial infarction ( emi ) .
C0032143
rt-pa
C0027051
myocardial infarction